COVID-19 Impact on Global Trigeminal Neuralgia Therapeutics Market Size, Status and Forecast 2020-2026

September 2020 | 93 pages | ID: CCFA2863A2D6EN
QYResearch

Abstracts

This report focuses on the global Trigeminal Neuralgia Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Trigeminal Neuralgia Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Allergan, Inc.
• Biogen, Inc.
• Kineta, Inc.
• Merz Pharma GmbH & Co. KgaA
• Trigemina, Inc.

Market segment by Type, the product can be split into

• NeuroRelease TN
• Onabotulinumtoxin A
• Oxytocin
• Raxatrigine Hydrochloride
• U-2902
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Trigeminal Neuralgia Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Trigeminal Neuralgia Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Trigeminal Neuralgia Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Trigeminal Neuralgia Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Trigeminal Neuralgia Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 NeuroRelease TN
  1.4.3 Onabotulinumtoxin A
  1.4.4 Oxytocin
  1.4.5 Raxatrigine Hydrochloride
  1.4.6 U-2902
  1.4.7 Others
1.5 Market by Application
  1.5.1 Global Trigeminal Neuralgia Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Trigeminal Neuralgia Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Trigeminal Neuralgia Therapeutics Industry
    1.6.1.1 Trigeminal Neuralgia Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Trigeminal Neuralgia Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Trigeminal Neuralgia Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Trigeminal Neuralgia Therapeutics Market Perspective (2015-2026)
2.2 Trigeminal Neuralgia Therapeutics Growth Trends by Regions
  2.2.1 Trigeminal Neuralgia Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Trigeminal Neuralgia Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Trigeminal Neuralgia Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Trigeminal Neuralgia Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Trigeminal Neuralgia Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Trigeminal Neuralgia Therapeutics Players by Market Size
  3.1.1 Global Top Trigeminal Neuralgia Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Trigeminal Neuralgia Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Trigeminal Neuralgia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Trigeminal Neuralgia Therapeutics Market Concentration Ratio
  3.2.1 Global Trigeminal Neuralgia Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Trigeminal Neuralgia Therapeutics Revenue in 2019
3.3 Trigeminal Neuralgia Therapeutics Key Players Head office and Area Served
3.4 Key Players Trigeminal Neuralgia Therapeutics Product Solution and Service
3.5 Date of Enter into Trigeminal Neuralgia Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Trigeminal Neuralgia Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Trigeminal Neuralgia Therapeutics Forecasted Market Size by Type (2021-2026)

5 TRIGEMINAL NEURALGIA THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020)
5.2 Global Trigeminal Neuralgia Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Trigeminal Neuralgia Therapeutics Market Size (2015-2020)
6.2 Trigeminal Neuralgia Therapeutics Key Players in North America (2019-2020)
6.3 North America Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020)
6.4 North America Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Trigeminal Neuralgia Therapeutics Market Size (2015-2020)
7.2 Trigeminal Neuralgia Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020)
7.4 Europe Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Trigeminal Neuralgia Therapeutics Market Size (2015-2020)
8.2 Trigeminal Neuralgia Therapeutics Key Players in China (2019-2020)
8.3 China Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020)
8.4 China Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Trigeminal Neuralgia Therapeutics Market Size (2015-2020)
9.2 Trigeminal Neuralgia Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020)
9.4 Japan Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Trigeminal Neuralgia Therapeutics Market Size (2015-2020)
10.2 Trigeminal Neuralgia Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Trigeminal Neuralgia Therapeutics Market Size (2015-2020)
11.2 Trigeminal Neuralgia Therapeutics Key Players in India (2019-2020)
11.3 India Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020)
11.4 India Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Trigeminal Neuralgia Therapeutics Market Size (2015-2020)
12.2 Trigeminal Neuralgia Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Allergan, Inc.
  13.1.1 Allergan, Inc. Company Details
  13.1.2 Allergan, Inc. Business Overview and Its Total Revenue
  13.1.3 Allergan, Inc. Trigeminal Neuralgia Therapeutics Introduction
  13.1.4 Allergan, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2015-2020))
  13.1.5 Allergan, Inc. Recent Development
13.2 Biogen, Inc.
  13.2.1 Biogen, Inc. Company Details
  13.2.2 Biogen, Inc. Business Overview and Its Total Revenue
  13.2.3 Biogen, Inc. Trigeminal Neuralgia Therapeutics Introduction
  13.2.4 Biogen, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2015-2020)
  13.2.5 Biogen, Inc. Recent Development
13.3 Kineta, Inc.
  13.3.1 Kineta, Inc. Company Details
  13.3.2 Kineta, Inc. Business Overview and Its Total Revenue
  13.3.3 Kineta, Inc. Trigeminal Neuralgia Therapeutics Introduction
  13.3.4 Kineta, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2015-2020)
  13.3.5 Kineta, Inc. Recent Development
13.4 Merz Pharma GmbH & Co. KgaA
  13.4.1 Merz Pharma GmbH & Co. KgaA Company Details
  13.4.2 Merz Pharma GmbH & Co. KgaA Business Overview and Its Total Revenue
  13.4.3 Merz Pharma GmbH & Co. KgaA Trigeminal Neuralgia Therapeutics Introduction
  13.4.4 Merz Pharma GmbH & Co. KgaA Revenue in Trigeminal Neuralgia Therapeutics Business (2015-2020)
  13.4.5 Merz Pharma GmbH & Co. KgaA Recent Development
13.5 Trigemina, Inc.
  13.5.1 Trigemina, Inc. Company Details
  13.5.2 Trigemina, Inc. Business Overview and Its Total Revenue
  13.5.3 Trigemina, Inc. Trigeminal Neuralgia Therapeutics Introduction
  13.5.4 Trigemina, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2015-2020)
  13.5.5 Trigemina, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Trigeminal Neuralgia Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Trigeminal Neuralgia Therapeutics Revenue
Table 3. Ranking of Global Top Trigeminal Neuralgia Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Trigeminal Neuralgia Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of NeuroRelease TN
Table 6. Key Players of Onabotulinumtoxin A
Table 7. Key Players of Oxytocin
Table 8. Key Players of Raxatrigine Hydrochloride
Table 9. Key Players of U-2902
Table 10. Key Players of Others
Table 11. COVID-19 Impact Global Market: (Four Trigeminal Neuralgia Therapeutics Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Trigeminal Neuralgia Therapeutics Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Trigeminal Neuralgia Therapeutics Players to Combat Covid-19 Impact
Table 16. Global Trigeminal Neuralgia Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Trigeminal Neuralgia Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Trigeminal Neuralgia Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Trigeminal Neuralgia Therapeutics Market Share by Regions (2015-2020)
Table 20. Global Trigeminal Neuralgia Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Trigeminal Neuralgia Therapeutics Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Trigeminal Neuralgia Therapeutics Market Growth Strategy
Table 26. Main Points Interviewed from Key Trigeminal Neuralgia Therapeutics Players
Table 27. Global Trigeminal Neuralgia Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 28. Global Trigeminal Neuralgia Therapeutics Market Share by Players (2015-2020)
Table 29. Global Top Trigeminal Neuralgia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Trigeminal Neuralgia Therapeutics as of 2019)
Table 30. Global Trigeminal Neuralgia Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Trigeminal Neuralgia Therapeutics Product Solution and Service
Table 33. Date of Enter into Trigeminal Neuralgia Therapeutics Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. Global Trigeminal Neuralgia Therapeutics Market Size Share by Type (2015-2020)
Table 37. Global Trigeminal Neuralgia Therapeutics Revenue Market Share by Type (2021-2026)
Table 38. Global Trigeminal Neuralgia Therapeutics Market Size Share by Application (2015-2020)
Table 39. Global Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. Global Trigeminal Neuralgia Therapeutics Market Size Share by Application (2021-2026)
Table 41. North America Key Players Trigeminal Neuralgia Therapeutics Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Trigeminal Neuralgia Therapeutics Market Share (2019-2020)
Table 43. North America Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. North America Trigeminal Neuralgia Therapeutics Market Share by Type (2015-2020)
Table 45. North America Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. North America Trigeminal Neuralgia Therapeutics Market Share by Application (2015-2020)
Table 47. Europe Key Players Trigeminal Neuralgia Therapeutics Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Trigeminal Neuralgia Therapeutics Market Share (2019-2020)
Table 49. Europe Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Trigeminal Neuralgia Therapeutics Market Share by Type (2015-2020)
Table 51. Europe Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Trigeminal Neuralgia Therapeutics Market Share by Application (2015-2020)
Table 53. China Key Players Trigeminal Neuralgia Therapeutics Revenue (2019-2020) (Million US$)
Table 54. China Key Players Trigeminal Neuralgia Therapeutics Market Share (2019-2020)
Table 55. China Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. China Trigeminal Neuralgia Therapeutics Market Share by Type (2015-2020)
Table 57. China Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. China Trigeminal Neuralgia Therapeutics Market Share by Application (2015-2020)
Table 59. Japan Key Players Trigeminal Neuralgia Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Trigeminal Neuralgia Therapeutics Market Share (2019-2020)
Table 61. Japan Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Trigeminal Neuralgia Therapeutics Market Share by Type (2015-2020)
Table 63. Japan Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Trigeminal Neuralgia Therapeutics Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Trigeminal Neuralgia Therapeutics Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Trigeminal Neuralgia Therapeutics Market Share (2019-2020)
Table 67. Southeast Asia Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Trigeminal Neuralgia Therapeutics Market Share by Type (2015-2020)
Table 69. Southeast Asia Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Trigeminal Neuralgia Therapeutics Market Share by Application (2015-2020)
Table 71. India Key Players Trigeminal Neuralgia Therapeutics Revenue (2019-2020) (Million US$)
Table 72. India Key Players Trigeminal Neuralgia Therapeutics Market Share (2019-2020)
Table 73. India Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. India Trigeminal Neuralgia Therapeutics Market Share by Type (2015-2020)
Table 75. India Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. India Trigeminal Neuralgia Therapeutics Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Trigeminal Neuralgia Therapeutics Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Trigeminal Neuralgia Therapeutics Market Share (2019-2020)
Table 79. Central & South America Trigeminal Neuralgia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Trigeminal Neuralgia Therapeutics Market Share by Type (2015-2020)
Table 81. Central & South America Trigeminal Neuralgia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Trigeminal Neuralgia Therapeutics Market Share by Application (2015-2020)
Table 83. Allergan, Inc. Company Details
Table 84. Allergan, Inc. Business Overview
Table 85. Allergan, Inc. Product
Table 86. Allergan, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2015-2020) (Million US$)
Table 87. Allergan, Inc. Recent Development
Table 88. Biogen, Inc. Company Details
Table 89. Biogen, Inc. Business Overview
Table 90. Biogen, Inc. Product
Table 91. Biogen, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2015-2020) (Million US$)
Table 92. Biogen, Inc. Recent Development
Table 93. Kineta, Inc. Company Details
Table 94. Kineta, Inc. Business Overview
Table 95. Kineta, Inc. Product
Table 96. Kineta, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2015-2020) (Million US$)
Table 97. Kineta, Inc. Recent Development
Table 98. Merz Pharma GmbH & Co. KgaA Company Details
Table 99. Merz Pharma GmbH & Co. KgaA Business Overview
Table 100. Merz Pharma GmbH & Co. KgaA Product
Table 101. Merz Pharma GmbH & Co. KgaA Revenue in Trigeminal Neuralgia Therapeutics Business (2015-2020) (Million US$)
Table 102. Merz Pharma GmbH & Co. KgaA Recent Development
Table 103. Trigemina, Inc. Company Details
Table 104. Trigemina, Inc. Business Overview
Table 105. Trigemina, Inc. Product
Table 106. Trigemina, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2015-2020) (Million US$)
Table 107. Trigemina, Inc. Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Trigeminal Neuralgia Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. NeuroRelease TN Features
Figure 3. Onabotulinumtoxin A Features
Figure 4. Oxytocin Features
Figure 5. Raxatrigine Hydrochloride Features
Figure 6. U-2902 Features
Figure 7. Others Features
Figure 8. Global Trigeminal Neuralgia Therapeutics Market Share by Application: 2020 VS 2026
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Trigeminal Neuralgia Therapeutics Report Years Considered
Figure 13. Global Trigeminal Neuralgia Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Trigeminal Neuralgia Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Trigeminal Neuralgia Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Trigeminal Neuralgia Therapeutics Market Share by Players in 2019
Figure 18. Global Top Trigeminal Neuralgia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Trigeminal Neuralgia Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Trigeminal Neuralgia Therapeutics Revenue in 2019
Figure 20. North America Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Allergan, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Allergan, Inc. Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2015-2020)
Figure 29. Biogen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Biogen, Inc. Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2015-2020)
Figure 31. Kineta, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Kineta, Inc. Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2015-2020)
Figure 33. Merz Pharma GmbH & Co. KgaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Merz Pharma GmbH & Co. KgaA Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2015-2020)
Figure 35. Trigemina, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Trigemina, Inc. Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed